These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

45 related items for PubMed ID: 16507424

  • 1. Efficacy of mycophenolic acid combined with KRP-203, a novel immunomodulator, in a rat heart transplantation model.
    Suzuki C, Takahashi M, Morimoto H, Izawa A, Ise H, Fujishiro J, Murakami T, Ishiyama J, Nakada A, Nakayama J, Shimada K, Ikeda U, Kobayashi E.
    J Heart Lung Transplant; 2006 Mar; 25(3):302-9. PubMed ID: 16507424
    [Abstract] [Full Text] [Related]

  • 2. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E.
    Circulation; 2005 Jan 18; 111(2):222-9. PubMed ID: 15642767
    [Abstract] [Full Text] [Related]

  • 3. Change from cyclosporine to combination therapy of mycophenolic acid with the new sphingosine-1-phosphate receptor agonist, KRP-203, prevents host nephrotoxicity and transplant vasculopathy in rats.
    Fujishiro J, Suzuki C, Kudou S, Yasue T, Hakamata Y, Takahashi M, Murakami T, Hashizume K, Kobayashi E.
    J Heart Lung Transplant; 2006 Jul 18; 25(7):825-33. PubMed ID: 16818126
    [Abstract] [Full Text] [Related]

  • 4. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
    Takahashi M, Shimizu H, Murakami T, Enosawa S, Suzuki C, Takeno Y, Hakamata Y, Kudou S, Izawa S, Yasue T, Kobayashi E.
    Transplant Proc; 2005 Jul 18; 37(1):143-5. PubMed ID: 15808575
    [Abstract] [Full Text] [Related]

  • 5. Use of sphingosine-1-phosphate 1 receptor agonist, KRP-203, in combination with a subtherapeutic dose of cyclosporine A for rat renal transplantation.
    Fujishiro J, Kudou S, Iwai S, Takahashi M, Hakamata Y, Kinoshita M, Iwanami S, Izawa S, Yasue T, Hashizume K, Murakami T, Kobayashi E.
    Transplantation; 2006 Sep 27; 82(6):804-12. PubMed ID: 17006328
    [Abstract] [Full Text] [Related]

  • 6. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun 27; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 7. A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice.
    Song J, Matsuda C, Kai Y, Nishida T, Nakajima K, Mizushima T, Kinoshita M, Yasue T, Sawa Y, Ito T.
    J Pharmacol Exp Ther; 2008 Jan 27; 324(1):276-83. PubMed ID: 17898319
    [Abstract] [Full Text] [Related]

  • 8. Renoprotective immunosuppression by pioglitazone with low-dose cyclosporine in rat heart transplantation.
    Tanaka Y, Hasegawa T, Chen Z, Okita Y, Okada K.
    J Thorac Cardiovasc Surg; 2009 Sep 27; 138(3):744-51. PubMed ID: 19698865
    [Abstract] [Full Text] [Related]

  • 9. A novel sphingosine-1-phosphate receptor agonist KRP-203 attenuates rat autoimmune myocarditis.
    Ogawa R, Takahashi M, Hirose S, Morimoto H, Ise H, Murakami T, Yasue T, Kuriyama K, Hongo M, Kobayashi E, Ikeda U.
    Biochem Biophys Res Commun; 2007 Sep 28; 361(3):621-8. PubMed ID: 17673173
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS, Partovi N, Levy RD, Riggs KW, Ensom MH.
    Ther Drug Monit; 2008 Jun 28; 30(3):282-91. PubMed ID: 18520599
    [Abstract] [Full Text] [Related]

  • 11. Rosiglitazone suppresses cyclosporin-induced chronic transplant dysfunction and prolongs survival of rat cardiac allografts.
    Chen Y, Liu Y, Yuan Z, Tian L, Dallman MJ, Thompson PW, Tam PK, Lamb JR.
    Transplantation; 2007 Jun 27; 83(12):1602-10. PubMed ID: 17589344
    [Abstract] [Full Text] [Related]

  • 12. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY, Wang XH, Zhang F, Li XC, Yao AH, Yu Y, Lv L, Li GQ.
    Surgery; 2007 Jul 27; 142(1):67-73. PubMed ID: 17630002
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable lung transplant recipients.
    Ting LS, Partovi N, Levy RD, Riggs KW, Ensom MH.
    Ann Pharmacother; 2006 Sep 27; 40(9):1509-16. PubMed ID: 16882870
    [Abstract] [Full Text] [Related]

  • 14. Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications.
    Weimert NA, Derotte M, Alloway RR, Woodle ES, Vinks AA.
    Ther Drug Monit; 2007 Apr 27; 29(2):141-9. PubMed ID: 17417067
    [Abstract] [Full Text] [Related]

  • 15. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
    Mino Y, Naito T, Matsushita T, Otsuka A, Ushiyama T, Ozono S, Hishida A, Kagawa Y, Kawakami J.
    Ther Drug Monit; 2008 Dec 27; 30(6):656-61. PubMed ID: 18978521
    [Abstract] [Full Text] [Related]

  • 16. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR, Huang CW, Goto S, Wang CT, Hsu LW, Lin YC, Yang KD, Chen CL, Lee WP.
    J Surg Res; 2009 May 15; 153(2):317-25. PubMed ID: 19101689
    [Abstract] [Full Text] [Related]

  • 17. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
    Zhang W, Liu M, Wu Y, Zhu P, Yin C, Zhang W, Gu M.
    J Surg Res; 2007 Dec 15; 143(2):428-36. PubMed ID: 17628598
    [Abstract] [Full Text] [Related]

  • 18. Combined treatment with triptolide and rapamycin prolongs graft survival in a mouse model of cardiac transplantation.
    Liu Y, Chen Y, Liu FQ, Lamb JR, Tam PK.
    Transpl Int; 2008 May 15; 21(5):483-94. PubMed ID: 18266776
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells.
    Cicinnati VR, Hou J, Lindemann M, Horn PA, Sotiropoulos GC, Paul A, Gerken G, Beckebaum S.
    Transplantation; 2009 Aug 27; 88(4):504-13. PubMed ID: 19696633
    [Abstract] [Full Text] [Related]

  • 20. Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus.
    Patel CG, Harmon M, Gohh RY, Akhlaghi F.
    Ther Drug Monit; 2007 Feb 27; 29(1):87-95. PubMed ID: 17304155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.